Skip to content

Genetic Association of Glucocorticoid Receptor Gene Polymorphisms With Binge Eating

Genetic Association of Glucocorticoid Receptor Gene Polymorphisms With Binge Eating Disorders in Type 2 Diabetic Obese Female Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04786054
Enrollment
91
Registered
2021-03-08
Start date
2019-01-01
Completion date
2021-02-01
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Behavior, Binge-Eating Disorder, Diabetes Type 2, Eating Disorders, Obesity

Brief summary

The aim of the present study was to specifically screen obese diabetic adolescent female individuals for BED, checking the variants of the GR gene (rs56149945; rs41423247) amongst identified individuals, and this led to assessing the impact of binge eating disorders on glycaemic control in obese diabetic adolescent females in Pakistan, South Asia.

Detailed description

Challenges in eating for diabetic adolescents can be categorized as eating disorders (ED) and disordered eating symptoms (DES). Binge-eating disorder (BED) is defined as recurrent episodes of binge eating at least once a week over a three-month time period and it is accompanied by feeling the lack of control and marked distress over one's eating behaviour. The aim of the present study was to specifically screen obese diabetic adolescent female individuals for BED, checking the variants of the GR gene (rs56149945; rs41423247) amongst identified individuals, and this led to assessing the impact of binge eating disorders on glycaemic control in obese diabetic adolescent females in Pakistan, South Asia.

Interventions

DIAGNOSTIC_TESTBED Questionnaire

BED Questionnaire

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
10 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Unmarried females diagnosed with Type 2 diabetes \> 12 months * Age 10-19 years * Obesity class I and II (based on BMI range of 30 - 40).

Exclusion criteria

* Presence of psychosis, major psychiatric or neurocognitive disorder * Substance use * Untreated attention-deficit hyperactivity disorder * Use of psychopharmacological medications or psychotherapy * Class III obesity

Design outcomes

Primary

MeasureTime frameDescription
BEDBaselinePresence of BED detected by individuals who score high on the BEDS7 Questionnaire administered

Secondary

MeasureTime frameDescription
NR3C1 Presence of variants of the GR gene (rs56149945; rs41423247)Six months into the study after identifying all individuals who scored high on the BEDS7 QuestionnairePresence of variants of the GR gene (rs56149945; rs41423247)

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026